Clinical Trial Update: Cognitive Enhancement Through Transcranial Laser Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on transcranial laser therapy for cognitive enhancement in healthy participants and individuals with mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Healthy Participants

Snippet

Sponsor: University of Texas at Austin | Conditions: Healthy Participants, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2023-10-04